Trademark: IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Track updates on IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY
Mark Identification
IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY
Click here to search for trademarks similar to IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY
Proof of use for IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY
We do not have any records of a proof of use for IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY at this moment.
Click here to add a proof of use for IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY
Possible trademark infringements of IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY
Basic Information about IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY
- Serial Number
- 87982366
- Filing Date
- 23 Jun 2017
- Registration Number
- 5968278
- Registration Date
- 21 Jan 2020
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY on the blockchain with WikiTrademarks.io.
- First use of IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY anywhere
- IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY was first used on 17 Apr 2019 for the primary classification of goods and services, international, 001 (Chemicals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 001
- US Codes
- 001; 005; 006; 010; 026; 046
- First use of IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY anywhere
- IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY was first used on 17 Apr 2019 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
- First use of IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY anywhere
- IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY was first used on 31 Oct 2018 for the primary classification of goods and services, international, 044 (Medical, beauty & agricultural)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 044
- US Codes
- 100; 101
Who owns IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY?
1. IOVANCE BIOTHERAPEUTICS, INC. SAN CARLOS CA
2. IOVANCE BIOTHERAPEUTICS, INC. SAN CARLOS CA
3. IOVANCE BIOTHERAPEUTICS, INC. SAN CARLOS CA
4. Lion Biotechnologies, Inc. San Carlos CA
Correspondent
- Carla B. Oakley
- MORGAN, LEWIS & BOCKIUS LLP
- One Market, Spear Street Tower
- SAN FRANCISCO CA 94105
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io
Track updates on IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY